Seasonal influenza in the United States, France, and Australia: transmission and prospects for control

被引:196
作者
Chowell, G. [1 ]
Miller, M. A. [2 ]
Viboud, C. [2 ]
机构
[1] Los Alamos Natl Lab, Theoret Div MS B284, Los Alamos, NM 87544 USA
[2] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1017/S0950268807009144
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Recurrent epidemics of influenza are observed seasonally around the world with considerable health and economic consequences. A key quantity for the control of infectious diseases is the reproduction number, which measures the transmissibility of a pathogen and determines the magnitude of public health interventions necessary to control epidemics. Here we applied a simple epidemic model to weekly indicators Of influenza mortality to estimate the reproduction numbers of seasonal influenza epidemics spanning three decades in the United States, France, and Australia.. We found similar distributions of reproduction number estimates in the three countries, with mean Value 1 center dot 3 and important year-to-year variability (range 0 center dot 9-2 center dot 1). Estimates derived from two different mortality indicators (pneumonia and influenza excess deaths and influenza-specific deaths) were in close agreement for the United States (correlation=0 center dot 61, P<0 center dot 001) and France (correlation =07 center dot 9, P<0 center dot 001), but not Australia. Interestingly, high prevalence of A/H3N2 influenza viruses was associated with high transmission seasons (P=0 center dot 006), while B Viruses were more prevalent in low transmission seasons (P = 0 center dot 004). The Current vaccination strategy targeted at people at highest risk of severe disease Outcome IS suboptimal because Current vaccines are poorly immunogenic in these Population groups. Our results Suggest that interrupting transmission of seasonal influenza would require a relatively high vaccination coverage (>60 in healthy individuals who respond well to vaccine, in addition to periodic re-vaccination due to evolving viral antigens and waning Population immunity.
引用
收藏
页码:852 / 864
页数:13
相关论文
共 73 条
  • [1] ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255
  • [2] ANDERSON R M, 1991
  • [4] [Anonymous], 1978, BMJ-BRIT MED J, V1, P587
  • [5] SURVIVAL OF INFLUENZA-VIRUSES ON ENVIRONMENTAL SURFACES
    BEAN, B
    MOORE, BM
    STERNER, B
    PETERSON, LR
    GERDING, DN
    BALFOUR, HH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (01) : 47 - 51
  • [6] STUDIES ON INFLUENZA IN THE PANDEMIC OF 1957-1958 .1. EPIDEMIOLOGIC, CLINICAL AND SEROLOGIC INVESTIGATION OF AN INTRAHOSPITAL EPIDEMIC, WITH A NOTE ON VACCINATION EFFICACY
    BLUMENFELD, HL
    KILBOURNE, ED
    LOURIA, DB
    ROGERS, DE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (01) : 199 - 212
  • [7] Transmission of influenza: Implications for control in health care settings
    Bridges, CB
    Kuehnert, MJ
    Hall, CB
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) : 1094 - 1101
  • [8] Epidemic influenza and vitamin D
    Cannell, J. J.
    Vieth, R.
    Umhau, J. C.
    Holick, M. F.
    Grant, W. B.
    Madronich, S.
    Garland, C. F.
    Giovannucci, E.
    [J]. EPIDEMIOLOGY AND INFECTION, 2006, 134 (06) : 1129 - 1140
  • [9] A Bayesian MCMC approach to study transmission of influenza:: application to household longitudinal data
    Cauchemez, S
    Carrat, F
    Viboud, C
    Valleron, AJ
    Boëlle, PY
    [J]. STATISTICS IN MEDICINE, 2004, 23 (22) : 3469 - 3487
  • [10] *CDC, 2000, MMWR-MORBID MORTAL W, V49, P375